vs

Side-by-side financial comparison of Core Scientific, Inc. (CORZ) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.

Core Scientific, Inc. is the larger business by last-quarter revenue ($79.8M vs $62.1M, roughly 1.3× Cytek Biosciences, Inc.). Core Scientific, Inc. runs the higher net margin — 268.5% vs -70.9%, a 339.4% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -16.0%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-450.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -33.3%).

Core Scientific is a leading digital asset and high-performance computing infrastructure provider. It operates large energy-efficient data centers across North America, offering cryptocurrency mining services, colocation hosting for blockchain and AI clients, and custom high-performance computing solutions for enterprise tech segments.

Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.

CORZ vs CTKB — Head-to-Head

Bigger by revenue
CORZ
CORZ
1.3× larger
CORZ
$79.8M
$62.1M
CTKB
Growing faster (revenue YoY)
CTKB
CTKB
+24.1% gap
CTKB
8.1%
-16.0%
CORZ
Higher net margin
CORZ
CORZ
339.4% more per $
CORZ
268.5%
-70.9%
CTKB
More free cash flow
CTKB
CTKB
$449.0M more FCF
CTKB
$-1.8M
$-450.8M
CORZ
Faster 2-yr revenue CAGR
CTKB
CTKB
Annualised
CTKB
17.7%
-33.3%
CORZ

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CORZ
CORZ
CTKB
CTKB
Revenue
$79.8M
$62.1M
Net Profit
$214.2M
$-44.1M
Gross Margin
26.0%
52.9%
Operating Margin
-149.5%
-9.0%
Net Margin
268.5%
-70.9%
Revenue YoY
-16.0%
8.1%
Net Profit YoY
180.6%
-557.1%
EPS (diluted)
$-1.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CORZ
CORZ
CTKB
CTKB
Q4 25
$79.8M
$62.1M
Q3 25
$81.1M
$52.3M
Q2 25
$78.6M
$45.6M
Q1 25
$79.5M
$41.5M
Q4 24
$94.9M
$57.5M
Q3 24
$95.4M
$51.5M
Q2 24
$141.1M
$46.6M
Q1 24
$179.3M
$44.9M
Net Profit
CORZ
CORZ
CTKB
CTKB
Q4 25
$214.2M
$-44.1M
Q3 25
$-144.0M
$-5.5M
Q2 25
$-936.8M
$-5.6M
Q1 25
$576.3M
$-11.4M
Q4 24
$-265.5M
$9.6M
Q3 24
$-455.3M
$941.0K
Q2 24
$-902.2M
$-10.4M
Q1 24
$210.7M
$-6.2M
Gross Margin
CORZ
CORZ
CTKB
CTKB
Q4 25
26.0%
52.9%
Q3 25
4.8%
52.7%
Q2 25
6.4%
52.3%
Q1 25
10.3%
48.6%
Q4 24
5.0%
58.5%
Q3 24
-0.2%
56.3%
Q2 24
27.5%
54.6%
Q1 24
43.3%
51.3%
Operating Margin
CORZ
CORZ
CTKB
CTKB
Q4 25
-149.5%
-9.0%
Q3 25
-67.6%
-17.6%
Q2 25
-33.4%
-23.3%
Q1 25
-59.1%
-36.1%
Q4 24
-41.9%
5.2%
Q3 24
-43.2%
-8.2%
Q2 24
-64.3%
-18.3%
Q1 24
30.8%
-23.9%
Net Margin
CORZ
CORZ
CTKB
CTKB
Q4 25
268.5%
-70.9%
Q3 25
-177.6%
-10.5%
Q2 25
-1191.4%
-12.2%
Q1 25
724.6%
-27.5%
Q4 24
-279.7%
16.8%
Q3 24
-477.4%
1.8%
Q2 24
-639.4%
-22.4%
Q1 24
117.5%
-13.8%
EPS (diluted)
CORZ
CORZ
CTKB
CTKB
Q4 25
$-1.63
Q3 25
$-0.45
Q2 25
$-0.04
Q1 25
$1.24
Q4 24
$0.51
Q3 24
$-1.17
Q2 24
$-5.05
Q1 24
$0.78

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CORZ
CORZ
CTKB
CTKB
Cash + ST InvestmentsLiquidity on hand
$311.4M
$90.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$-962.7M
$341.7M
Total Assets
$2.3B
$461.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CORZ
CORZ
CTKB
CTKB
Q4 25
$311.4M
$90.9M
Q3 25
$453.4M
$93.3M
Q2 25
$581.3M
$75.5M
Q1 25
$697.9M
$95.3M
Q4 24
$836.2M
$98.7M
Q3 24
$253.0M
$162.3M
Q2 24
$96.1M
$177.9M
Q1 24
$98.1M
$168.8M
Stockholders' Equity
CORZ
CORZ
CTKB
CTKB
Q4 25
$-962.7M
$341.7M
Q3 25
$-1.3B
$378.6M
Q2 25
$-1.2B
$377.6M
Q1 25
$-308.8M
$379.6M
Q4 24
$-943.0M
$395.7M
Q3 24
$-826.7M
$385.5M
Q2 24
$-1.2B
$389.1M
Q1 24
$-318.5M
$392.6M
Total Assets
CORZ
CORZ
CTKB
CTKB
Q4 25
$2.3B
$461.5M
Q3 25
$2.2B
$494.9M
Q2 25
$1.9B
$493.3M
Q1 25
$1.5B
$482.6M
Q4 24
$1.5B
$499.5M
Q3 24
$824.6M
$491.2M
Q2 24
$664.2M
$483.7M
Q1 24
$814.0M
$492.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CORZ
CORZ
CTKB
CTKB
Operating Cash FlowLast quarter
$278.3M
$-771.0K
Free Cash FlowOCF − Capex
$-450.8M
$-1.8M
FCF MarginFCF / Revenue
-565.1%
-2.9%
Capex IntensityCapex / Revenue
914.0%
1.6%
Cash ConversionOCF / Net Profit
1.30×
TTM Free Cash FlowTrailing 4 quarters
$-779.8M
$-8.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CORZ
CORZ
CTKB
CTKB
Q4 25
$278.3M
$-771.0K
Q3 25
$131.8M
$-3.9M
Q2 25
$34.0M
$108.0K
Q1 25
$-45.0M
$-125.0K
Q4 24
$42.9M
$2.0M
Q3 24
$5.7M
$13.2M
Q2 24
$1.2M
$6.2M
Q1 24
$22.2M
$4.0M
Free Cash Flow
CORZ
CORZ
CTKB
CTKB
Q4 25
$-450.8M
$-1.8M
Q3 25
$-112.7M
$-4.6M
Q2 25
$-87.3M
$-1.5M
Q1 25
$-129.0M
$-974.0K
Q4 24
$-52.1M
$1.1M
Q3 24
$-25.5M
$12.2M
Q2 24
$-1.9M
$5.2M
Q1 24
$-9.7M
$3.4M
FCF Margin
CORZ
CORZ
CTKB
CTKB
Q4 25
-565.1%
-2.9%
Q3 25
-139.0%
-8.7%
Q2 25
-111.0%
-3.2%
Q1 25
-162.2%
-2.3%
Q4 24
-54.8%
1.9%
Q3 24
-26.7%
23.7%
Q2 24
-1.4%
11.0%
Q1 24
-5.4%
7.6%
Capex Intensity
CORZ
CORZ
CTKB
CTKB
Q4 25
914.0%
1.6%
Q3 25
301.5%
1.3%
Q2 25
154.2%
3.5%
Q1 25
105.6%
2.0%
Q4 24
100.0%
1.6%
Q3 24
32.7%
2.0%
Q2 24
2.2%
2.3%
Q1 24
17.8%
1.3%
Cash Conversion
CORZ
CORZ
CTKB
CTKB
Q4 25
1.30×
Q3 25
Q2 25
Q1 25
-0.08×
Q4 24
0.21×
Q3 24
14.05×
Q2 24
Q1 24
0.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CORZ
CORZ

Other$36.3M46%
Digital Asset Self Mining Service$31.8M40%
Colocation Service$11.6M15%

CTKB
CTKB

Products$46.6M75%
Services$15.5M25%

Related Comparisons